Login
$RVTY
$161.86 +$1.47 (0.92%) Close

$RVTY 3 SEC Filings

Filed On Filing
01 Feb 2024 Form 3: Klobuchar Michael A, Director

No securities owned

01 Feb 2024 Form 3: Vandebroek Sophie V., Director

No securities owned

16 Jun 2023 Form 3: Gonzales Anita, Please See Remarks

Holds 3,282 shares of Common Stock

06 Sep 2022 Form 3: Krakowiak Maxwell, Please See Remarks

Holds 970 shares of Common Stock

25 Jul 2022 Form 3: McMurry-Heath Michelle, Director

No securities owned

05 Jan 2021 Form 3: Victor Miriame, Please See Remarks

Holds 5,354 shares of Common Stock

02 Mar 2020 Form 3: Vounatsos Michel, Director

No securities owned

01 May 2018 Form 3: Mock James M, Please See Remarks

No securities owned

01 Feb 2018 Form 3: Vohra Tajinder, Please See Remarks

Holds 3,991 shares of Common Stock

30 Oct 2017 Form 3: Witz Pascale, Director

No securities owned

17 Oct 2016 Form 3: Chapin Samuel R., Director

No securities owned

03 Oct 2016 Form 3: Singh Prahlad R., Please See Remarks

Holds 12,461 shares of Common Stock

27 Jul 2016 Form 3: Witney Frank, Director

Holds 80 shares of Common Stock

11 Jul 2016 Form 3: Butters Deborah A., Please See Remarks

No securities owned

05 Feb 2016 Form 3: Tereau Daniel R, Please See Remarks

Holds 6,305 shares of Common Stock

10 Feb 2015 Form 3: Gregoire Sylvie, Director

No securities owned

03 Dec 2013 Form 3: DiVincenzo Jonathan, See Remarks

No securities owned

06 Feb 2012 Form 3: Corbett James, S V P, President Diagnostics

Holds 13,537 shares of Common Stock

06 Feb 2012 Form 3: Hrusovsky E Kevin, See Remarks
06 Feb 2012 Form 3: Tenney Maurice H., See Remarks

Holds 16,563 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support